BioTelemetryBEAT recently announced the receipt of CE mark for its Holter analysis software. This approval is expected to exclusively strengthen the company's foothold in the growing Holter monitoring ...
It certainly wouldn't qualify as a bloodbath, but make no mistake about it -- it was the worst day the broad-based S&P 500 has seen in quite some time. The primary culprit that caused the markets to ...
Shares ofBioTelemetry(NASDAQ: BEAT), a medical device company focused primarily on mobile cardiac monitoring, are up more than 16% as of 11:45 a.m. EDT on Wednesday. The huge jump is attributable to ...
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story stocks' without revenue, let alone profit. And in their study titled Who Falls Prey ...
BioTelemetry, Inc. BEAT is set to report third-quarter 2018 results on Oct 30, after market close. The company delivered an earnings surprise of 48.4% in the last reported quarter. BioTelemetry beat ...
Add Yahoo as a preferred source to see more of our stories on Google. MALVERN, Pa. (AP) -- Shares of wireless medical device maker BioTelemetry jumped Monday after the company announced it had ...
BioTelemetry, a technology company focused on health information delivery, has acquired Telcare, a digital diabetes management platform. Telcare developed the first FDA-cleared cellular enabled blood ...
Scaling down electronics isn't only important when building consumer devices, it also has a hufe impact on the world of implantable medical devices. However, as with all things technological, ...
Philips announced this past week that it will acquire BioTelemetry, a provider of remote cardiac diagnostics and monitoring, for $2.8 billion. The transaction is expected to be completed in the first ...
Two nationally recognized healthcare companies settled separate multimillion dollar claims tied to False Claims Act (FCA) violations, highlighting the continued scrutiny that providers face from ...
BioTelemetry (BEAT) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.52 per share a year ago. These figures ...
Researchers are the first to characterize the ecology and fine-scale habitat use of 'near threatened' whitespotted eagle rays in Florida while also identifying areas of potential interactions between ...